Clinical Biochemical Genetics · Los Angeles, CA
NPI
1154515963
Since 2007
Specialty
Clinical Biochemical Genetics
Code 207SG0202X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
4650 W Sunset Blvd, Mail Stop # 90
Los Angeles, CA, 90027
Phone (323) 361-2178
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$3.1M
203 prescriptions
Company payments, 2025
$0
From 3 companies
Medicare prescription drug claims, 2024
In 2024, the drug Divya Vats prescribed most often to Medicare patients was Galafold (Migalastat Hcl), with 53 prescriptions and refills. In total Divya Vats wrote 203 Medicare prescriptions that cost $3.1M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-08.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Galafold Migalastat Hcl | 53 | 53 | Under 11 | $1.6M |
| Cerdelga Eliglustat Tartrate | 45 | 45 | Under 11 | $959K |
| Albuterol Sulfate Generic | 32 | 37 | Under 11 | $1,822 |
| Palynziq Pegvaliase-Pqpz | 14 | 14 | Under 11 | $177K |
| Tizanidine Hcl Generic | 11 | 11 | Under 11 | $157 |
Brand drugs: 124 claims; generic drugs: 79 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Divya Vats $0 (- in general payments such as food, travel and fees) from 3 companies.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.